1/29/15


Spark Therapeutics, which is developing gene therapy treatments for orphan retinal dystrophies, raised $161 million in an upsized IPO by offering 7 million shares at $23, above the upwardly revised range of $19 to $21. Spark Therapeutics plans to list on the NASDAQ under the symbol [ONCE]. Spark Therapeutics initially filed confidentially on 9/24/2014. J.P. Morgan and Credit Suisse acted as lead managers on the deal....more


Keywords: ONCE

1/29/15


Shake Shack, a well-known upscale fast-casual burger chain with 63 restaurants across 31 cities and nine countries, raised $105 million by offering 5 million shares at $21, above the upwardly revised range of $17 to $19. The New York, NY-based company had initially filed to offer the same number of shares at a range of $14 to $16. At the offer price, Shake Shack commands a fully diluted market cap of $751 million (enterprise value of $680 million). Shake Shack will list on the NYSE under the symbol [SHAK]. J.P. Morgan, Morgan Stanley, Barclays, Goldman Sachs and Jefferies & Co. acted as ...more


Keywords: SHAK

1/29/15


Sol-Wind Renewable Power LP, which owns a portfolio of contracted solar generation assets, announced terms for its IPO on Thursday. The New York, NY-based company plans to raise $174 million by offering 8.7 million units at a price range of $19 to $21. At the midpoint of the proposed range, it would command a fully diluted market value of $401 million. Renewable energy yieldco IPOs in 2014 included Abengoa Yield ([ABY]; +17%) and TerraForm Power ([TERP]; +30%), both of which priced above their proposed range. Sol-Wind Renewable Power LP, which was founded in 2014 and booked $24 ...more


Keywords: SLWD, TERP, ABY

1/29/15


Inovalon Holdings, which provides healthcare analytics to payors, providers and pharmas, announced terms for its IPO on Thursday. The Bowie, MD-based company plans to raise $500 million by offering 22.2 million shares at a price range of $21 to $24. At the midpoint of the proposed range, Inovalon would command a fully diluted market value of $3.4 billion. Last year's healthcare data IPO, TPG-backed IMS Health ([IMS]), trades 25% above its offer price. Inovalon Holdings, which was founded in 1998 and booked $336 million in sales for the 12 months ended September 30, 2014, plans to ...more


Keywords: INOV, IMS

Archived News Headlines
Performance Disclosure: Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.

As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund’s average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees. An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The Renaissance IPO Index® (IPOUSA) is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The Renaissance International IPO Index® (IPOXUS) is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges. The S&P 500® Index (SPX) is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE.

Risk Disclosure: Investments in the Renaissance IPO ETF, symbol "IPO", the Renaissance International IPO ETF, symbol "IPOS" (the “ETFs”), and the Global IPO Fund, symbol "IPOSX" (the “Mutual Fund”) are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the “Funds”) invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.

Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit www.renaissancecapital.com. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.